NB-202

N/A

Report date: 2025/02/13 16:49:28

Base Information

Drug NameNB-202
Drug Alias NameNB202NB-202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-PD-1Anti-Hepatitis A virus cellular receptor 2
TargetsProgrammed cell death protein 1Hepatitis A virus cellular receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNeoLogics Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeoLogics Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A